Rekombinanter FOLR1 (Farletuzumab Biosimilar) Antikörper

Produktnummer ABIN7581415

Produktdetails anti-FOLR1 (Farletuzumab Biosimilar) Antikörper

Target: FOLR1 (Farletuzumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Human

Expressionssystem: CHO Cells

Klonalität: Monoklonal

Konjugat: Dieser FOLR1 (Farletuzumab Biosimilar) Antikörper ist unkonjugiert

Applikation: ELISA, Functional Studies (Func), Flow Cytometry (FACS), Surface Plasmon Resonance (SPR), Bio-Layer Interferometry (BLI)

Verwendungszweck: Anti-FOLR1 / FRA Reference Antibody (farletuzumab)

Sequenz: EVQLVESGGG VVQPGRSLRL SCSASGFTFS GYGLSWVRQA PGKGLEWVAM ISSGGSYTYY ADSVKGRFAI SRDNAKNTLF LQMDSLRPED TGVYFCARHG DDPAWFAYWG QGTPVTVSSA STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ QGNVFSCSVM HEALHNHYTQ KSLSLSPGK,DIQLTQSPSS LSASVGDRVT ITCSVSSSIS SNNLHWYQQK PGKAPKPWIY GTSNLASGVP SRFSGSGSGT DYTFTISSLQ PEDIATYYCQ QWSSYPYMYT FGQGTKVEIK RTVAAPSVFI FPPSDEQLKS GTASVVCLLN NFYPREAKVQ WKVDNALQSG NSQESVTEQD SKDSTYSLSS TLTLSKADYE KHKVYACEVT HQGLSSPVTK SFNRGEC

Produktmerkmale: Anti-FOLR1 Reference Antibody (farletuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 144.12 kDa.

Reinheit: >95 %

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Kommentare:

Therapeutic Agents by Target and Mechanism: FOLR1 antagonist

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Lagerung: 4 °C,-80 °C

Informationen zur Lagerung: +4°C,-80°C

Details zu FOLR1 (Farletuzumab Biosimilar)

Target: FOLR1 (Farletuzumab Biosimilar)

Substanzklasse: Biosimilar

Molekulargewicht: 144.12 kDa

UniProt: P15328